Cargando…
A new technique for the analysis of metabolic pathways of cytidine analogues and cytidine deaminase activities in cells
Deoxycytidine analogues (dCas) are widely used for the treatment of malignant diseases. They are commonly inactivated by cytidine deaminase (CDD), or by deoxycytidine monophosphate deaminase (dCMP deaminase). Additional metabolic pathways, such as phosphorylation, can substantially contribute to the...
Autores principales: | Ligasová, Anna, Piskláková, Barbora, Friedecký, David, Koberna, Karel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665361/ https://www.ncbi.nlm.nih.gov/pubmed/37993628 http://dx.doi.org/10.1038/s41598-023-47792-4 |
Ejemplares similares
-
Activation induced cytidine deaminase: An old friend with new faces
por: Çakan, Elif, et al.
Publicado: (2022) -
Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase
por: Narvaiza, Iñigo, et al.
Publicado: (2009) -
Activation-induced Cytidine Deaminase in B Cell Immunity and Cancers
por: Park, Seok-Rae
Publicado: (2012) -
Cytidine deaminase activity increases in the blood of breast cancer patients
por: Buhagiar-Labarchède, Géraldine, et al.
Publicado: (2022) -
The fallout from crossing paths with cellular cytidine deaminases
por: Wain-Hobson, Simon, et al.
Publicado: (2009)